PHIBRO (PAHC) CEO Daniel Bendheim Sells 486 Shares for Tax Withholding

What Happened

Daniel M. Bendheim, President & CEO and a director of PHIBRO ANIMAL HEALTH CORP (PAHC), had 486 shares disposed on 2026-08-04 at $36.60 per share for a total of $17,787. The filing reports this disposition was to satisfy tax withholding obligations related to the vesting and settlement of restricted stock units (RSUs), not an open-market sell for investment reasons.

Key Details

• Transaction date: 2026-08-04
• Price and value: 486 shares × $36.60 = $17,787
• Transaction type: Reported as "Other acquisition or disposition (J)"; footnote F1 states shares were sold in a broker-assisted cashless exercise to satisfy tax withholding on RSU settlement.
• Filing date: Form 4 filed 2026-08-06 (covers the Aug 4 transaction) — appears timely based on the Form 4 reporting window.
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context

• This was a routine cashless sale to cover taxes on RSU vesting, a common administrative transaction that does not necessarily indicate the insider's view on the company's stock.
• For retail investors, purchases or open-market sales by insiders may carry more informational weight; tax-withholding dispositions are typically neutral from a sentiment perspective.